Biovision (Drug Discovery) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B1

  • Investors
  • 18

Biovision (Drug Discovery) General Information

Description

Developer of targeted radiopharmaceuticals designed to treat cancer and serious diseases. The company's technology utilises targeted ligand screening, radiopharmaceutical conjugation, clinical translation, isotope labelling, imaging evaluation, and multifunctional conjugation, enabling healthcare providers to achieve non-invasive early visual diagnosis and evaluate therapeutic effects.

Contact Information

Website
www.bivisionpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room C9-205
  • Number 2555 Xiupu Road, Pudong New Area
  • Shanghai, 211899
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room C9-205
  • Number 2555 Xiupu Road, Pudong New Area
  • Shanghai, 211899
  • China
+86 021

Biovision (Drug Discovery) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biovision (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B1) 14-Sep-2026 Completed Generating Revenue
5. Early Stage VC (Series B) 18-May-2026 Completed Generating Revenue
4. Early Stage VC (Series A1) 10-Jan-2025 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Jul-2024 Completed Generating Revenue
2. Early Stage VC 01-Jul-2022 $14.9M $14.9M Completed Generating Revenue
1. Seed Round 01-Aug-2021 Completed Startup
To view Biovision (Drug Discovery)’s complete valuation and funding history, request access »

Biovision (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted radiopharmaceuticals designed to treat cancer and serious diseases. The company's technology utili
Drug Discovery
Shanghai, China
25 As of 2024

Chengdu, China
 

Suzhou, China
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biovision (Drug Discovery) Competitors (3)

One of Biovision (Drug Discovery)’s 3 competitors is C-Ray, a Venture Capital-Backed company based in Chengdu, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
C-Ray Venture Capital-Backed Chengdu, China
SmartNuclide Venture Capital-Backed Suzhou, China
CStone Pharmaceuticals Formerly VC-backed Suzhou, China
You’re viewing 3 of 3 competitors. Get the full list »

Biovision (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biovision (Drug Discovery) Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fuho Capital Venture Capital Minority
Shangshan Goldstone Capital Growth/Expansion Minority
Guohai Innovation Capital Investment Management Corporate Venture Capital Minority
IDG Capital Venture Capital Minority
Jiangsu Winfast Investment Asset Manager Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Biovision (Drug Discovery) FAQs

  • When was Biovision (Drug Discovery) founded?

    Biovision (Drug Discovery) was founded in 2021.

  • Where is Biovision (Drug Discovery) headquartered?

    Biovision (Drug Discovery) is headquartered in Shanghai, China.

  • What is the size of Biovision (Drug Discovery)?

    Biovision (Drug Discovery) has 25 total employees.

  • What industry is Biovision (Drug Discovery) in?

    Biovision (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Biovision (Drug Discovery) a private or public company?

    Biovision (Drug Discovery) is a Private company.

  • What is Biovision (Drug Discovery)’s current revenue?

    The current revenue for Biovision (Drug Discovery) is .

  • How much funding has Biovision (Drug Discovery) raised over time?

    Biovision (Drug Discovery) has raised $101M.

  • Who are Biovision (Drug Discovery)’s investors?

    Fuho Capital, Shangshan Goldstone Capital, Guohai Innovation Capital Investment Management, IDG Capital, and Jiangsu Winfast Investment are 5 of 18 investors who have invested in Biovision (Drug Discovery).

  • Who are Biovision (Drug Discovery)’s competitors?

    C-Ray, SmartNuclide, and CStone Pharmaceuticals are competitors of Biovision (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process